During the past decade, Mayo Clinic Nicotine Research Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Nicotine Research Program" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator and "Ortho-McNeil Janssen Scientific Affairs, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Nicotine Research Program" are "ADHD" (1 trials), "Cigarette Smoking" (1 trials), "Smoking" (1 trials), "Tobacco Abstinence" (1 trials) and "Tobacco Use" (1 trials). Many other conditions were trialed in "Mayo Clinic Nicotine Research Program" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Nicotine Research Program" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Gabapentin - 1800 mg/day" (1 trials), "Gabapentin - 2700 mg/day" (1 trials), "Osmotic-Release Methylphenidate" (1 trials) and "Varenicline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Nicotine Research Program" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mayo Clinic Nicotine Research Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mayo Clinic Nicotine Research Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Nicotine Research Program, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".